Innovative Technology Platforms: How They Are Paying Off for Big Pharma and BiotechDecision Resources
September 1, 2010
More Research & Development reports by Decision Resources
TreatmentTrends®: Advanced/Metastatic Breast Cancer (US) 2012 by Decision Resources
This report series examines the current trends in the management of Advanced / Metastatic Breast Cancer from the perspective of medical oncologists. TreatmentTrends® are syndicated ...
Rheumatoid Arthritis in Brazil, Russia, and China – How Are Payers and Prescribers Promoting or Limiting Growth in the Biologics Markets by Decision Resources
This report is based on a survey of 150 prescribers (rheumatologists) and interviews with 12 payers. Interviewed payers have influence at a national ...
LaunchTrends®: Abatacept SC (Orencia SC) (Wave 4) 2012 by Decision Resources
This report is a series of four post-launch reports that evaluates the trial and usage of ORENCIA SC (abatacept) among rheumatologists for the treatment of ...
Niche Markets and Rare Diseases: Graft Versus Host Disease by Decision ResourcesSee all reports like this >>
Graft versus host disease (GVHD) is a life-threatening complication that hampers the efficacy of hematopoietic stem cell transplants (HCST) to treat hematological malignancies. ...
We can help you find what you need. Call us or write us:
Need help in your search?
Research & Development Reports